What happens when you increase your Wegovy dose

What physically changes in your body when the dose goes up?

Semaglutide works by binding to GLP-1 receptors in the brain, gut and pancreas. At higher doses, that binding is more sustained: the hypothalamus receives a stronger satiety signal, gastric emptying slows further, and insulin release becomes more tightly matched to meals. The practical result is that food feels less interesting and portions that once felt modest now feel adequate.

The flip side of that deeper effect is a more pronounced influence on the digestive tract itself. The gut has GLP-1 receptors too, and a dose increase can briefly irritate them before your system adjusts. That is why nausea, queasiness and occasionally vomiting cluster in the days immediately after stepping up. A detailed breakdown of each Wegovy dose and what to expect at each level explains how the tolerability profile shifts across the full schedule. NHS guidance on tirzepatide and semaglutide both confirm that GI effects are most prominent during initiation and each upward step, and generally settle within one to two weeks. The NHS semaglutide medicines page lists the common effects by frequency and gives guidance on when they warrant medical advice.

Injection-site reactions can also change slightly after a dose increase; rotating your site between abdomen, thigh and upper arm each week reduces localised irritation. Fatigue and mild headache are reported by some people in the adjustment window and tend to be short-lived.

Does a higher Wegovy dose mean faster or greater weight loss?

Generally, yes — though with two important caveats. First, the relationship is not simply linear: some people achieve strong results at 1.7 mg and see only a modest additional benefit from 2.4 mg, while others respond markedly to the final step. Second, results depend heavily on the dietary and activity changes running alongside treatment; a higher dose amplifies the effect of those changes rather than replacing them.

The STEP 1 trial, published in the New England Journal of Medicine, found that adults on semaglutide 2.4 mg achieved around 15% average body-weight reduction over 68 weeks, a figure that encompasses those who titrated successfully to the full maintenance dose. Participants who could not tolerate 2.4 mg remained at their highest tolerated dose, so real-world outcomes at lower maintenance doses are also represented in the wider evidence base.

If you are curious about what happens when someone starts at the highest dose rather than titrating gradually, this page covers the risks and reasons behind starting Wegovy at 2.4 mg. Spoiler: it is not recommended.

The 7.2 mg Wegovy pen, approved by the MHRA in April 2026, represents a further step beyond the previous 2.4 mg ceiling and reported approximately 20.7% average weight loss over 72 weeks in trials, approaching tirzepatide results. Availability of specific doses and pen formats is confirmed at consultation.

How bad are the side effects after a dose increase, and how long do they last?

Honest answer: variable. Some people barely notice the step up; others spend a few days managing nausea, skipping large meals and sipping fluids carefully. The severity tends to correlate loosely with how quickly you are moving through the schedule and how sensitive your gut was at the previous dose. If 0.5 mg caused you two weeks of nausea, expect the 1.0 mg step to need similar patience.

The symptom pattern most people describe is: an increase in queasiness in the first three to five days post-injection, sometimes peaking around day two or three, then gradually settling. Eating smaller, lower-fat meals during that window helps. Staying well hydrated is important, particularly if you experience loose stools, because dehydration can compound other side effects.

Severe or persistent stomach pain (especially pain that radiates to the back) is different in character from ordinary nausea and should not be attributed to a normal dose-increase response. The MHRA's Yellow Card reporting system exists for exactly these situations; use it if you experience something that concerns you, and seek medical help promptly for severe abdominal pain.

A question our prescribers hear regularly: is it normal to feel worse after stepping up, even if the previous dose was going well? Yes, it is. That earlier settled feeling will return once your body adjusts to the new level. Most people find three to four weeks is enough. If side effects remain unmanageable, your prescriber may hold the current dose for longer rather than continuing the titration.

Who decides when (and whether) your dose actually increases?

Your prescriber does. Not the calendar, not the pen in your fridge, and not a patient forum. The typical four-week interval between dose steps is a minimum, not a target that must be hit regardless of how you feel. The clinical reasoning behind Wegovy dose-increase timing covers what prescribers weigh up (tolerance, weight response, any comorbidities) in more detail.

At nume, every repeat order triggers a fresh clinical review by a GPhC-registered Independent Prescriber. A real clinician reads your update, not software. That review considers whether your current dose is working, whether you're managing any side effects, and whether the next step is appropriate now or should wait. If you want to understand the signs that indicate you are ready to move up, this guide walks through the key indicators your prescriber will look for before increasing your Wegovy dose.

There are also situations where a dose increase is not the right move at all: if you've had a recent illness causing prolonged vomiting or diarrhoea, if you're due surgery shortly, or if there are new medications interacting with absorption. Our FAQs cover common questions about what to tell your prescriber at review. If you missed a dose in the week leading up to a planned increase, that is another variable worth flagging, missed doses have their own considerations that can affect timing.

If you're weighing up whether Wegovy suits your situation at all, or want to explore the full picture of private weight-loss treatment options, you can review what is available through a free consultation with our prescribers. No commitment, no waiting list.